Skip to main content
SpringerLink
Log in

Praxis der Kombinations- und Augmentationsbehandlung bei Nichtansprechen auf antidepressive Monotherapie

  • Chapter
  • First Online:
Book cover Therapie der Depression

  • 13k Accesses

Zusammenfassung

Dieses Kapitel behandelt die wichtigsten Kombinations- und Augmentationsbehandlungen bei Nichtansprechen auf eine antidepressive Monotherapie. Nach einer Definition der verschiedenen Stadien der Therapieresistenz depressiver Erkrankungen wird in Therapiebausteinen ein Überblick über die Auswahl geeigneter Kombinations- und Augmentationspartner sowie über allgemeine Therapieprinzipien, Nebenwirkungen und Risiken und darüber hinaus über Interaktionen und Kontraindikationen der dargestellten Therapieoptionen gegeben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Appelberg BG, Syvalahti EK, Koskinen TE et al (2001) Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. J Clin Psychiatry 62:448–452

    Article  CAS  PubMed  Google Scholar 

  • Aronson R, Offman HJ, Joffe RT et al (1996) Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 53:842–848

    Article  CAS  PubMed  Google Scholar 

  • Ballesteros J, Callado LF (2004) Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. J Affect Disord 79:137–147

    Article  CAS  PubMed  Google Scholar 

  • Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Moller HJ (2013) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 14:334–385

    Article  PubMed  Google Scholar 

  • Blier P, Gobbi G, Turcotte JE et al (2009) Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination. Eur Neuropsychopharmaocl 19:457–465

    Article  CAS  Google Scholar 

  • Blier P, Ward HE, Tremblayx P et al (2010) Combination of antidepressant medications form treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry 167:281–288

    Article  PubMed  Google Scholar 

  • Boukoms A, Mangini L (1993) Pergolide: an antidepressant adjuvant for mood disorders? Psychopharmacol Bull 29: 207–211

    Google Scholar 

  • Connolly KR, Thase ME (2011) If at first you don’t succeed. Drugs 7:43–46

    Article  Google Scholar 

  • DGPPN et al (DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW [Hrsg] für die Leitliniengruppe Unipolare Depression*) (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Aufl, Vers 2. (*Organisationen, die in der Leitliniengruppe kooperierten: DGPPN, BÄK, KBV, AWMF, ACKPA, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW, BDK, BDP, BPM, BVDN, BVDP, BVVP, CPKA, DÄVT, DFT, DGGPP, DGPT, DGVT, DPG, DPV, DPtV, DVT, GwG, Stiftung Deutsche Depressionshilfe). doi:10.6101/AZQ/000266. http//:www.depression.versorgungsleitlinien.de. Zugegriffen: 11. Apr. 2016

  • Erbe S, Gutwinski S, Bschor T (2012) Augmentation von Antidepressiva mit atypischen Antipsychotika bei Nonresponse auf eine Antidepressiva-Monotherapie. Psychiat Prax 39:57–63

    Article  Google Scholar 

  • Goldberg JF, Burdick KE, Endick CJ (2004) Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 161:564–566

    Article  PubMed  Google Scholar 

  • Joffe RT, Singer W (1990) A comparison of triiodothyronin and thyroxine in the potentiation of tricylcic antidepressants. Psychiatry Res 32:241–251

    Article  CAS  PubMed  Google Scholar 

  • Hüttemann K, Nowe T, Köhrmann M et al (2009) Maligne Hyperthermie und deren Differentialdiagnosen. Fortschr Neurol Psychiat 77:203–211

    Article  PubMed  Google Scholar 

  • Möller HJ Seemüller F, Schennach-Wolf R et al (2014) History, background, concepts and current use of comedication and polypharmacy in psychiatry. Int J Neuropsychopharmacology 17:983–996

    Article  Google Scholar 

  • Nelson JC, Papakostas GI (2009) Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 166:980–991

    Article  PubMed  Google Scholar 

  • Nierenberg AA, Fava M, Trivedi MH (2006) A comparison of lithium and T3 augmentation following two failed medication treatments for depression: A Star*D report. Am J Psychiatry 163:1519–1530

    Article  PubMed  Google Scholar 

  • Pande AC, Calarco MM, Grunhaus LJ (1991) Combined MAOI-TCA treatment in refractory depression. In: Amsterdam JD (Hrsg) Advances in neuropsychiatry and psychopharmacology, vol 2: Refractory depression. Raven Press, New York NY, S 115–121

    Google Scholar 

  • Papakostas GI (2010) Switching, combination, and augmentation strategies for major depressive disorder. Ann Clin Psychiatry 22:9–14

    Google Scholar 

  • Papakostas GI, Shelton RC, Smith J et al (2007) Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. J Clin Psychiatry 68:826–831

    Article  CAS  PubMed  Google Scholar 

  • Papakostas GI, Mischoulon D, Shyu I et al (2010) S-Adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 167:942–948

    Article  PubMed  Google Scholar 

  • Schmauß M, Messer T (2016) Polypharmazie in der Behandlung depressiver Störungen in: Messer T, Schmauß M (Hrsg.) Polypharmazie in der Behandlung psychischer Erkrankungen. 3. Aufl. Springer, Berlin, S 1–39

    Google Scholar 

  • Shelton RC, Papakostas GI (2008) Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Acta Psychiatr Scand 117:253–259

    Article  CAS  PubMed  Google Scholar 

  • Thase ME (2011) Antidepressant combinations: widely used, but far from empirically validated. Can J Psychiatry 56:317–323

    Article  PubMed  Google Scholar 

  • Thase ME, Rush AJ (1997) When at first you don’t succeed: sequential strategies for antidepressant nonresponsers. J Clin Psychiatry 58 Suppl 13:23–29

    PubMed  Google Scholar 

  • Trivedi MH, Fava M, Wisniewski SR et al (2006) Medication augmentation after the failure of SSRIs for depression. N Engl J Med 12:1243–1252

    Article  Google Scholar 

  • Wijkstra J, Lijmers J, Burger H et al (2015) Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev 7:CD004044.doi: 10.1002/14651858

    Google Scholar 

  • Zhou X, Pavindran AV, Qin B et al (2015) Comparative efficacy, acceptability and tolerability of augmentation agents in treatment resistant depression: systematic review and network meta-analysis. J Clin Psychiatry 76 (4):e487–e498

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Bezirkskrankenhaus Augsburg, Dr.-Mack-Str.1, 86156, Augsburg, Deutschland

    Max Schmauß

  2. Danuvius Klinik GmbH, Krankenhausstr.68, 85276, Pfaffenhofen, Deutschland

    Thomas Messer

Authors
  1. Max Schmauß
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Messer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Max Schmauß .

Editor information

Editors and Affiliations

  1. Zentrum für Psychosoziale Medizin, Agaplesion Diakonieklinikum Rotenburg, Rotenburg, Germany

    Carsten Konrad

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Schmauß, M., Messer, T. (2017). Praxis der Kombinations- und Augmentationsbehandlung bei Nichtansprechen auf antidepressive Monotherapie. In: Konrad, C. (eds) Therapie der Depression. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50347-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50347-8_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50346-1

  • Online ISBN: 978-3-662-50347-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation